Department of Veterinary Surgery, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, People's Republic of China.
Acta Vet Scand. 2023 Feb 3;65(1):4. doi: 10.1186/s13028-023-00668-z.
The emergence of multidrug resistance among enterococci makes effective treatment of enterococcal infections more challenging. Giant pandas (Ailuropoda melanoleuca) are vulnerable to oral trauma and lesions as they feast on bamboo. Enterococci may contaminate such oral lesions and cause infection necessitating treatment with antibiotics. However, few studies have focused on the virulence and drug resistance of oral-derived enterococci, including Enterococcus faecium, in giant pandas. In this study, we analyzed the prevalence of 8 virulence genes and 14 drug resistance genes in E. faecium isolates isolated from saliva samples of giant pandas held in captivity in China and examined the antimicrobial drug susceptibility patterns of the E. faecium isolates.
Twenty-eight isolates of E. faecium were successfully isolated from the saliva samples. Four virulence genes were detected, with the acm gene showing the highest prevalence (89%). The cylA, cpd, esp, and hyl genes were not detected. The isolated E. faecium isolates possessed strong resistance to a variety of drugs; however, they were sensitive to high concentrations of aminoglycosides. The resistance rates to vancomycin, linezolid, and nitrofurantoin were higher than those previously revealed by similar studies in China and other countries.
The findings of the present study indicate the drugs of choice for treatment of oral E. faecium infection in the giant panda.
肠球菌中出现的多药耐药性使得肠球菌感染的有效治疗更加具有挑战性。大熊猫(Ailuropoda melanoleuca)在以竹子为食时容易遭受口腔创伤和病变。肠球菌可能会污染这些口腔病变并导致感染,需要使用抗生素进行治疗。然而,很少有研究关注来自大熊猫口腔的肠球菌(包括屎肠球菌)的毒力和耐药性。在本研究中,我们分析了从中国圈养大熊猫唾液样本中分离出的屎肠球菌分离株中 8 种毒力基因和 14 种耐药基因的流行情况,并检测了屎肠球菌分离株的抗菌药物敏感性模式。
从唾液样本中成功分离出 28 株屎肠球菌。检测到 4 种毒力基因,其中 acm 基因的检出率最高(89%)。未检测到 cylA、cpd、esp 和 hyl 基因。分离出的屎肠球菌对多种药物具有较强的耐药性;然而,它们对高浓度氨基糖苷类药物敏感。屎肠球菌对万古霉素、利奈唑胺和呋喃妥因的耐药率高于中国和其他国家类似研究中先前报道的耐药率。
本研究结果表明,对于大熊猫口腔屎肠球菌感染的治疗,可选择这些药物。